Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fahad Quhal

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Molecular Carcinogenesis|September 29, 2021
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladderEkaterina Laukhtina, Victor M Schuettfort, David D'Andrea, et al.
Journal of Cancer Research and Clinical Oncology|January 8, 2022
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancerSatoshi Katayama, Victor M Schuettfort, Benjamin Pradere, et al.
European Urology Open Science|May 9, 2022
Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter StudyNico C Grossmann, Pawel Rajwa, Fahad Quhal, et al.
European Urology Focus|August 29, 2021
The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical CystectomyKeiichiro Mori, Victor M Schuettfort, Satoshi Katayama, et al.
BJU International|August 10, 2023
Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysisEkaterina Laukhtina, Markus von Deimling, Benjamin Pradere, et al.
Arab Journal of Urology|January 5, 2024
Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancerPawel Rajwa, Fahad Quhal, David D'Andrea, et al.
World Journal of Urology|May 20, 2022
Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter studyEkaterina Laukhtina, Axelle Boehm, Benoit Peyronnet, et al.
European Urology|April 25, 2022
Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysisPawel Rajwa, Benjamin Pradere, Giorgio Gandaglia, et al.
Targeted Oncology|November 13, 2024
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Molecular Carcinogenesis|September 29, 2021
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladderEkaterina Laukhtina, Victor M Schuettfort, David D'Andrea, et al.
Journal of Cancer Research and Clinical Oncology|January 8, 2022
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancerSatoshi Katayama, Victor M Schuettfort, Benjamin Pradere, et al.
European Urology Open Science|May 9, 2022
Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter StudyNico C Grossmann, Pawel Rajwa, Fahad Quhal, et al.
European Urology Focus|August 29, 2021
The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical CystectomyKeiichiro Mori, Victor M Schuettfort, Satoshi Katayama, et al.
BJU International|August 10, 2023
Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysisEkaterina Laukhtina, Markus von Deimling, Benjamin Pradere, et al.
Arab Journal of Urology|January 5, 2024
Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancerPawel Rajwa, Fahad Quhal, David D'Andrea, et al.
World Journal of Urology|May 20, 2022
Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter studyEkaterina Laukhtina, Axelle Boehm, Benoit Peyronnet, et al.
European Urology|April 25, 2022
Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysisPawel Rajwa, Benjamin Pradere, Giorgio Gandaglia, et al.
Targeted Oncology|November 13, 2024
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
Pageof 14